期刊文献+

磷脂酶A2-ⅡA在直肠癌中的表达及临床意义

The expression and clinical significance of secretory phospholipase A2 groupⅡA in rectal cancer
下载PDF
导出
摘要 目的:探讨磷脂酶A2-ⅡA(PLA2-ⅡA)在直肠癌患者中的表达和临床意义。方法:采用免疫组化检测45例直肠癌标本、34例基本正常的直肠黏膜、32例直肠腺瘤组织中PLA2-ⅡA的表达水平,并观察PLA2-ⅡA表达水平与临床病理特征之间的关系。结果:直肠癌组PLA2-ⅡA表达水平明显高于直肠腺瘤组、正常组,差异有统计学意义(P<0.05);直肠腺瘤组PLA2-ⅡA表达水平高于正常组,但差异无统计学意义(P=0.677);PLA2-ⅡA阳性表达水平随着肿瘤浸润程度加重、分化程度降低、TNM分期升高、脉管侵犯而明显降低,差异有统计学意义(P<0.05)。结论:PLA2-ⅡA在直肠癌癌组织中高表达,与肿瘤浸润程度、分化程度、TNM分期、脉管是否侵犯、神经束是否侵犯有关,其可能在直肠癌的发生、发展中起重要的作用。 Objective: To explore the expression and clinical significance of Secretory phospholipase A2 group Ⅱ A (PLA2-ⅡA) in rectal cancer. Methods: 45 specimens of rectal cancer were collected. The immunohistochemical method was used to measure the expression of PLA2- Ⅱ A protein in the 45 specimens fo rectal cancer, in addition to 34 cases with normal rectal mucosa, 32 cases with rectal adrenoma. The relationships between PLA2- Ⅱ A and clinical factors were observed. Re- suits: In rectal cancer group, the expression of PLA2-Ⅱ A was significantly higher than that in the other groups (P〈0.05). Although expression of PLA2- Ⅱ A in rectal adenoma was higher than that in the normal group, but the difference was not significant (P=0. 677). The expression of PLA2- Ⅱ A obviously was declined with the higher degree of infitration, lower degree of differentiation, later stage of TNM, and vascular invasion invasion in the tumor tissue (P〈0.05). Conclusions: PLA2-Ⅱ A has a high expression in the rectal cancer patients, and it is associated with tumor infiltration depth, differentiation degree, TNM staging, whether it related to nerve tract invasion and vascular invasion or not. It may play an important role in the oc- curence and development of CRC.
作者 张平
出处 《海南医学院学报》 CAS 2015年第6期739-741,共3页 Journal of Hainan Medical University
基金 四川省卫生厅科学研究项目(140529)~~
关键词 磷脂酶A2-ⅡA 直肠癌 临床意义 Secretory phospholipase A2 group Ⅱ A Rectal cancer Clinical significance
  • 相关文献

参考文献13

  • 1Jemal A,Bray F,Center MM,et al. Global cancer statistics[J]. CA Cancer J Clin,2011,61(2) : 69-90.
  • 2张勇,蒋堃,王春阳,崔元琴,刘冬声,张佃良.PLA2G2A在胰腺癌组织中的表达及其与患者术后生存期的关系[J].中华胰腺病杂志,2013,13(5):337-339. 被引量:3
  • 3Wang X,Huang CJ,Yu GZ,et al. Expression of group IIA phos pholipase A2 is an independent predictor of favorable outcome for patients with gastric eancer[J]. Hum Pathol, 2013,44 (10) 2020 2027.
  • 4姚宏伟,刘荫华.第7版结直肠癌TNM分期(2010)更新内容解读[J].中华外科杂志,2010,48(21):1601-1604. 被引量:57
  • 5Six DA, Dennis EA. The expanding superfamily of phospho lipase A (2) enzymes: classification and characterization [J ] Bioehim Biophys Acta,2000,1488(1 2): 1 19.
  • 6Hong KH, Bonventre JC, O'Leary E, et al. Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigene sis[J].Proc NatlAcadSciU SA. 2001, 98(7): 3935 3939.
  • 7Ilsley JN, Nakanishi M, Flynn C, et al. Cytoplasmic phospho- lipase A2 deletion enhances colon tumorigenesis [J]. Cancer Res. 2005, 65(7): 2636-2643.
  • 8Fijneman RJ, Peham JR, van de Wiel MA, et al. Expression of Pla2g2a prevents carcinogenesis in Mue2-deficient mice [J]. Cancer Sei. 2008, 99(11): 2113-2119.
  • 9Tribler L, Jensen LT, Jorgensen K, et al. Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue[J]. Antican- cer Res. 2007, 27(5A): 3179 3185.
  • 10谭露露,梁宁生,张雷.ⅡA型磷脂酶A_2 mRNA在结、直肠癌组织中的表达水平及其意义[J].中国癌症防治杂志,2011,3(1):39-42. 被引量:3

二级参考文献45

  • 1陈晖,王承党.ⅡA分泌型磷脂酶A2与消化系统肿瘤关系的研究进展[J].肿瘤,2010,30(9):802-805. 被引量:4
  • 2李艳,梁宁生.血小板型磷脂酶A_2抗菌活性的研究进展[J].国外医学(临床生物化学与检验学分册),2005,26(10):694-696. 被引量:12
  • 3赵久达,贺菊香,耿排力.PLA2GⅡA基因在胃癌组织的表达及意义[J].山东医药,2006,46(10):24-25. 被引量:5
  • 4Greene FL,Page DL,Fleming ID,et al.AJCC Cancer Staging Manual.6th ed.New York:Springer,2002.
  • 5Edge SB,Byrd DR,Compton CC,et al.AJCC Cancer Staging Manual.7th ed.New York:Springer,2010.
  • 6Greene FL,Compton CC,Fritz AG,et al.AJCC Cancer Staging Atlas.New York:Springer,2006.
  • 7Ryan R,Gibbons D,Hyland JMP,et al.Pathological response following long-course neoadjuvant chemorediotherapy for locally advanced rectal cancer.Histopathology,2005,47:141-146.
  • 8Washington MK,Berlin J,Branton PA,et al.Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum.Arch Pathol Lab Med,2008,132:1182-1193.
  • 9NCCN Clinical Practice Guidelines in Oncology:colon cancer Ⅴ.2.2010.[EB/OL].[2009-12-18].http://www.nccn.org/professionals/physician_gls/PDF/colon.pdf.
  • 10NCCN Clinical Practice Guidelines in Oncology:rectal cancer Ⅴ.2.2010.[EB/OL].[2009-12-18].http://www.nccn.org/professionals/physician_gls/PDF/rectal.pdf.

共引文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部